Neurological outcomes at 18 months of age and neonatal risk factors for severe sequelae in congenitally cytomegalovirus-infected infants treated by antiviral treatment early in life
Gespeichert in:
| Autor*in: |
Morioka, Ichiro [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2017 |
|---|
| Übergeordnetes Werk: |
Enthalten in: The use of serum marker CA-125 in patients operated because of endometriosis - Georgievska, J. ELSEVIER, 2019, the international journal for experimental and clinical reproductive immunobiology, Oxford |
|---|---|
| Übergeordnetes Werk: |
volume:124 ; year:2017 ; pages:80 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jri.2017.10.028 |
|---|
| Katalog-ID: |
ELV041144856 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV041144856 | ||
| 003 | DE-627 | ||
| 005 | 20230624082802.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180725s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jri.2017.10.028 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000042.pica |
| 035 | |a (DE-627)ELV041144856 | ||
| 035 | |a (ELSEVIER)S0165-0378(17)30322-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 540 |a 610 |q VZ |
| 084 | |a 35.00 |2 bkl | ||
| 084 | |a 44.46 |2 bkl | ||
| 100 | 1 | |a Morioka, Ichiro |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neurological outcomes at 18 months of age and neonatal risk factors for severe sequelae in congenitally cytomegalovirus-infected infants treated by antiviral treatment early in life |
| 264 | 1 | |c 2017 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 700 | 1 | |a Fukushima, Sachiyo |4 oth | |
| 700 | 1 | |a Ohyama, Shohei |4 oth | |
| 700 | 1 | |a Nishida, Kosuke |4 oth | |
| 700 | 1 | |a Yamana, Keiji |4 oth | |
| 700 | 1 | |a Fujioka, Kazumichi |4 oth | |
| 700 | 1 | |a Iijima, Kazumoto |4 oth | |
| 700 | 1 | |a Morizane, Mayumi |4 oth | |
| 700 | 1 | |a Tanimura, Kenji |4 oth | |
| 700 | 1 | |a Deguchi, Masashi |4 oth | |
| 700 | 1 | |a Yamada, Hideto |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Oxford University Press |a Georgievska, J. ELSEVIER |t The use of serum marker CA-125 in patients operated because of endometriosis |d 2019 |d the international journal for experimental and clinical reproductive immunobiology |g Oxford |w (DE-627)ELV002243032 |
| 773 | 1 | 8 | |g volume:124 |g year:2017 |g pages:80 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jri.2017.10.028 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 35.00 |j Chemie: Allgemeines |q VZ |
| 936 | b | k | |a 44.46 |j Klinische Pathologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 124 |j 2017 |h 80 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
i m im |
|---|---|
| matchkey_str |
moriokaichirofukushimasachiyoohyamashohe:2017----:erlgclucmst8otsfgadentlikatrfreeeeulenogntlyyoeaoiuifceifn |
| hierarchy_sort_str |
2017 |
| bklnumber |
35.00 44.46 |
| publishDate |
2017 |
| allfields |
10.1016/j.jri.2017.10.028 doi GBV00000000000042.pica (DE-627)ELV041144856 (ELSEVIER)S0165-0378(17)30322-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 610 VZ 35.00 bkl 44.46 bkl Morioka, Ichiro verfasserin aut Neurological outcomes at 18 months of age and neonatal risk factors for severe sequelae in congenitally cytomegalovirus-infected infants treated by antiviral treatment early in life 2017 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Fukushima, Sachiyo oth Ohyama, Shohei oth Nishida, Kosuke oth Yamana, Keiji oth Fujioka, Kazumichi oth Iijima, Kazumoto oth Morizane, Mayumi oth Tanimura, Kenji oth Deguchi, Masashi oth Yamada, Hideto oth Enthalten in Oxford University Press Georgievska, J. ELSEVIER The use of serum marker CA-125 in patients operated because of endometriosis 2019 the international journal for experimental and clinical reproductive immunobiology Oxford (DE-627)ELV002243032 volume:124 year:2017 pages:80 https://doi.org/10.1016/j.jri.2017.10.028 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 44.46 Klinische Pathologie VZ AR 124 2017 80 045F 610 |
| spelling |
10.1016/j.jri.2017.10.028 doi GBV00000000000042.pica (DE-627)ELV041144856 (ELSEVIER)S0165-0378(17)30322-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 610 VZ 35.00 bkl 44.46 bkl Morioka, Ichiro verfasserin aut Neurological outcomes at 18 months of age and neonatal risk factors for severe sequelae in congenitally cytomegalovirus-infected infants treated by antiviral treatment early in life 2017 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Fukushima, Sachiyo oth Ohyama, Shohei oth Nishida, Kosuke oth Yamana, Keiji oth Fujioka, Kazumichi oth Iijima, Kazumoto oth Morizane, Mayumi oth Tanimura, Kenji oth Deguchi, Masashi oth Yamada, Hideto oth Enthalten in Oxford University Press Georgievska, J. ELSEVIER The use of serum marker CA-125 in patients operated because of endometriosis 2019 the international journal for experimental and clinical reproductive immunobiology Oxford (DE-627)ELV002243032 volume:124 year:2017 pages:80 https://doi.org/10.1016/j.jri.2017.10.028 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 44.46 Klinische Pathologie VZ AR 124 2017 80 045F 610 |
| allfields_unstemmed |
10.1016/j.jri.2017.10.028 doi GBV00000000000042.pica (DE-627)ELV041144856 (ELSEVIER)S0165-0378(17)30322-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 610 VZ 35.00 bkl 44.46 bkl Morioka, Ichiro verfasserin aut Neurological outcomes at 18 months of age and neonatal risk factors for severe sequelae in congenitally cytomegalovirus-infected infants treated by antiviral treatment early in life 2017 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Fukushima, Sachiyo oth Ohyama, Shohei oth Nishida, Kosuke oth Yamana, Keiji oth Fujioka, Kazumichi oth Iijima, Kazumoto oth Morizane, Mayumi oth Tanimura, Kenji oth Deguchi, Masashi oth Yamada, Hideto oth Enthalten in Oxford University Press Georgievska, J. ELSEVIER The use of serum marker CA-125 in patients operated because of endometriosis 2019 the international journal for experimental and clinical reproductive immunobiology Oxford (DE-627)ELV002243032 volume:124 year:2017 pages:80 https://doi.org/10.1016/j.jri.2017.10.028 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 44.46 Klinische Pathologie VZ AR 124 2017 80 045F 610 |
| allfieldsGer |
10.1016/j.jri.2017.10.028 doi GBV00000000000042.pica (DE-627)ELV041144856 (ELSEVIER)S0165-0378(17)30322-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 610 VZ 35.00 bkl 44.46 bkl Morioka, Ichiro verfasserin aut Neurological outcomes at 18 months of age and neonatal risk factors for severe sequelae in congenitally cytomegalovirus-infected infants treated by antiviral treatment early in life 2017 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Fukushima, Sachiyo oth Ohyama, Shohei oth Nishida, Kosuke oth Yamana, Keiji oth Fujioka, Kazumichi oth Iijima, Kazumoto oth Morizane, Mayumi oth Tanimura, Kenji oth Deguchi, Masashi oth Yamada, Hideto oth Enthalten in Oxford University Press Georgievska, J. ELSEVIER The use of serum marker CA-125 in patients operated because of endometriosis 2019 the international journal for experimental and clinical reproductive immunobiology Oxford (DE-627)ELV002243032 volume:124 year:2017 pages:80 https://doi.org/10.1016/j.jri.2017.10.028 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 44.46 Klinische Pathologie VZ AR 124 2017 80 045F 610 |
| allfieldsSound |
10.1016/j.jri.2017.10.028 doi GBV00000000000042.pica (DE-627)ELV041144856 (ELSEVIER)S0165-0378(17)30322-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 610 VZ 35.00 bkl 44.46 bkl Morioka, Ichiro verfasserin aut Neurological outcomes at 18 months of age and neonatal risk factors for severe sequelae in congenitally cytomegalovirus-infected infants treated by antiviral treatment early in life 2017 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Fukushima, Sachiyo oth Ohyama, Shohei oth Nishida, Kosuke oth Yamana, Keiji oth Fujioka, Kazumichi oth Iijima, Kazumoto oth Morizane, Mayumi oth Tanimura, Kenji oth Deguchi, Masashi oth Yamada, Hideto oth Enthalten in Oxford University Press Georgievska, J. ELSEVIER The use of serum marker CA-125 in patients operated because of endometriosis 2019 the international journal for experimental and clinical reproductive immunobiology Oxford (DE-627)ELV002243032 volume:124 year:2017 pages:80 https://doi.org/10.1016/j.jri.2017.10.028 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 44.46 Klinische Pathologie VZ AR 124 2017 80 045F 610 |
| language |
English |
| source |
Enthalten in The use of serum marker CA-125 in patients operated because of endometriosis Oxford volume:124 year:2017 pages:80 |
| sourceStr |
Enthalten in The use of serum marker CA-125 in patients operated because of endometriosis Oxford volume:124 year:2017 pages:80 |
| format_phy_str_mv |
Article |
| bklname |
Chemie: Allgemeines Klinische Pathologie |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
The use of serum marker CA-125 in patients operated because of endometriosis |
| authorswithroles_txt_mv |
Morioka, Ichiro @@aut@@ Fukushima, Sachiyo @@oth@@ Ohyama, Shohei @@oth@@ Nishida, Kosuke @@oth@@ Yamana, Keiji @@oth@@ Fujioka, Kazumichi @@oth@@ Iijima, Kazumoto @@oth@@ Morizane, Mayumi @@oth@@ Tanimura, Kenji @@oth@@ Deguchi, Masashi @@oth@@ Yamada, Hideto @@oth@@ |
| publishDateDaySort_date |
2017-01-01T00:00:00Z |
| hierarchy_top_id |
ELV002243032 |
| dewey-sort |
3610 |
| id |
ELV041144856 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV041144856</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624082802.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180725s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jri.2017.10.028</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000042.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV041144856</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0165-0378(17)30322-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.46</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Morioka, Ichiro</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Neurological outcomes at 18 months of age and neonatal risk factors for severe sequelae in congenitally cytomegalovirus-infected infants treated by antiviral treatment early in life</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fukushima, Sachiyo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ohyama, Shohei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nishida, Kosuke</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yamana, Keiji</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fujioka, Kazumichi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Iijima, Kazumoto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Morizane, Mayumi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tanimura, Kenji</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Deguchi, Masashi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yamada, Hideto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Oxford University Press</subfield><subfield code="a">Georgievska, J. ELSEVIER</subfield><subfield code="t">The use of serum marker CA-125 in patients operated because of endometriosis</subfield><subfield code="d">2019</subfield><subfield code="d">the international journal for experimental and clinical reproductive immunobiology</subfield><subfield code="g">Oxford</subfield><subfield code="w">(DE-627)ELV002243032</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:124</subfield><subfield code="g">year:2017</subfield><subfield code="g">pages:80</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jri.2017.10.028</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.00</subfield><subfield code="j">Chemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.46</subfield><subfield code="j">Klinische Pathologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">124</subfield><subfield code="j">2017</subfield><subfield code="h">80</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Morioka, Ichiro |
| spellingShingle |
Morioka, Ichiro ddc 610 ddc 540 bkl 35.00 bkl 44.46 Neurological outcomes at 18 months of age and neonatal risk factors for severe sequelae in congenitally cytomegalovirus-infected infants treated by antiviral treatment early in life |
| authorStr |
Morioka, Ichiro |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV002243032 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 540 - Chemistry & allied sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 540 610 VZ 35.00 bkl 44.46 bkl Neurological outcomes at 18 months of age and neonatal risk factors for severe sequelae in congenitally cytomegalovirus-infected infants treated by antiviral treatment early in life |
| topic |
ddc 610 ddc 540 bkl 35.00 bkl 44.46 |
| topic_unstemmed |
ddc 610 ddc 540 bkl 35.00 bkl 44.46 |
| topic_browse |
ddc 610 ddc 540 bkl 35.00 bkl 44.46 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
s f sf s o so k n kn k y ky k f kf k i ki m m mm k t kt m d md h y hy |
| hierarchy_parent_title |
The use of serum marker CA-125 in patients operated because of endometriosis |
| hierarchy_parent_id |
ELV002243032 |
| dewey-tens |
610 - Medicine & health 540 - Chemistry |
| hierarchy_top_title |
The use of serum marker CA-125 in patients operated because of endometriosis |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV002243032 |
| title |
Neurological outcomes at 18 months of age and neonatal risk factors for severe sequelae in congenitally cytomegalovirus-infected infants treated by antiviral treatment early in life |
| ctrlnum |
(DE-627)ELV041144856 (ELSEVIER)S0165-0378(17)30322-4 |
| title_full |
Neurological outcomes at 18 months of age and neonatal risk factors for severe sequelae in congenitally cytomegalovirus-infected infants treated by antiviral treatment early in life |
| author_sort |
Morioka, Ichiro |
| journal |
The use of serum marker CA-125 in patients operated because of endometriosis |
| journalStr |
The use of serum marker CA-125 in patients operated because of endometriosis |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2017 |
| contenttype_str_mv |
zzz |
| container_start_page |
80 |
| author_browse |
Morioka, Ichiro |
| container_volume |
124 |
| class |
610 610 DE-600 540 610 VZ 35.00 bkl 44.46 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Morioka, Ichiro |
| doi_str_mv |
10.1016/j.jri.2017.10.028 |
| dewey-full |
610 540 |
| title_sort |
neurological outcomes at 18 months of age and neonatal risk factors for severe sequelae in congenitally cytomegalovirus-infected infants treated by antiviral treatment early in life |
| title_auth |
Neurological outcomes at 18 months of age and neonatal risk factors for severe sequelae in congenitally cytomegalovirus-infected infants treated by antiviral treatment early in life |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Neurological outcomes at 18 months of age and neonatal risk factors for severe sequelae in congenitally cytomegalovirus-infected infants treated by antiviral treatment early in life |
| url |
https://doi.org/10.1016/j.jri.2017.10.028 |
| remote_bool |
true |
| author2 |
Fukushima, Sachiyo Ohyama, Shohei Nishida, Kosuke Yamana, Keiji Fujioka, Kazumichi Iijima, Kazumoto Morizane, Mayumi Tanimura, Kenji Deguchi, Masashi Yamada, Hideto |
| author2Str |
Fukushima, Sachiyo Ohyama, Shohei Nishida, Kosuke Yamana, Keiji Fujioka, Kazumichi Iijima, Kazumoto Morizane, Mayumi Tanimura, Kenji Deguchi, Masashi Yamada, Hideto |
| ppnlink |
ELV002243032 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.jri.2017.10.028 |
| up_date |
2024-07-06T19:20:51.787Z |
| _version_ |
1803858636216205312 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV041144856</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624082802.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180725s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jri.2017.10.028</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000042.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV041144856</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0165-0378(17)30322-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.46</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Morioka, Ichiro</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Neurological outcomes at 18 months of age and neonatal risk factors for severe sequelae in congenitally cytomegalovirus-infected infants treated by antiviral treatment early in life</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fukushima, Sachiyo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ohyama, Shohei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nishida, Kosuke</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yamana, Keiji</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fujioka, Kazumichi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Iijima, Kazumoto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Morizane, Mayumi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tanimura, Kenji</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Deguchi, Masashi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yamada, Hideto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Oxford University Press</subfield><subfield code="a">Georgievska, J. ELSEVIER</subfield><subfield code="t">The use of serum marker CA-125 in patients operated because of endometriosis</subfield><subfield code="d">2019</subfield><subfield code="d">the international journal for experimental and clinical reproductive immunobiology</subfield><subfield code="g">Oxford</subfield><subfield code="w">(DE-627)ELV002243032</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:124</subfield><subfield code="g">year:2017</subfield><subfield code="g">pages:80</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jri.2017.10.028</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.00</subfield><subfield code="j">Chemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.46</subfield><subfield code="j">Klinische Pathologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">124</subfield><subfield code="j">2017</subfield><subfield code="h">80</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.3994513 |